Literature DB >> 17922848

A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major.

Janine König1, Alan H Fairlamb.   

Abstract

The genome of Leishmania major, the causative agent of cutaneous leishmaniasis, contains three almost identical genes encoding putative glutathione peroxidases, which differ only at their N- and C-termini. Because the gene homologues are essential in trypanosomes, they may also represent potential drug targets in Leishmania. Recombinant protein for the shortest of these showed negligible peroxidase activity with glutathione as the electron donor indicating that it is not a bone fide glutathione peroxidase. By contrast, high peroxidase activity was obtained with tryparedoxin, indicating that these proteins belong to a new class of monomeric tryparedoxin-dependent peroxidases (TDPX) distinct from the classical decameric 2-Cys peroxiredoxins (TryP). Mass spectrometry studies revealed that oxidation of TDPX1 with peroxides results in the formation of an intramolecular disulfide bridge between Cys35 and Cys83. Site-directed mutagenesis and kinetic studies showed that Cys35 is essential for peroxidase activity, whereas Cys83 is essential for reduction by tryparedoxin. Detailed kinetic studies comparing TDPX1 and TryP1 showed that both enzymes obey saturation ping-pong kinetics with respect to tryparedoxin and peroxide. Both enzymes show high affinity for tryparedoxin and broad substrate specificity for hydroperoxides. TDPX1 shows higher affinity towards hydrogen peroxide and cumene hydroperoxide than towards t-butyl hydroperoxide, whereas no specific substrate preference could be detected for TryP1. TDPX1 exhibits rate constants up to 8 x 10(4) m(-1).s(-1), whereas TryP1 exhibits higher rate constants approximately 10(6) m(-1).s(-1). All three TDPX proteins together constitute approximately 0.05% of the L. major promastigote protein content, whereas the TryPs are approximately 40 times more abundant. Possible specific functions of TDPXs are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922848      PMCID: PMC3430366          DOI: 10.1111/j.1742-4658.2007.06087.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  44 in total

1.  Decomposition of protein tryptophan fluorescence spectra into log-normal components. III. Correlation between fluorescence and microenvironment parameters of individual tryptophan residues.

Authors:  Y K Reshetnyak; Y Koshevnik; E A Burstein
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

Review 2.  Peroxiredoxins.

Authors:  Birgit Hofmann; Hans-Jürgen Hecht; Leopold Flohé
Journal:  Biol Chem       Date:  2002 Mar-Apr       Impact factor: 3.915

3.  Cloning and characterization of three differentially expressed peroxidoxin genes from Leishmania chagasi. Evidence for an enzymatic detoxification of hydroxyl radicals.

Authors:  S D Barr; L Gedamu
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

4.  The Trypanosoma cruzi enzyme TcGPXI is a glycosomal peroxidase and can be linked to trypanothione reduction by glutathione or tryparedoxin.

Authors:  Shane R Wilkinson; David J Meyer; Martin C Taylor; Elizabeth V Bromley; Michael A Miles; John M Kelly
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

5.  A thiol peroxidase is an H2O2 receptor and redox-transducer in gene activation.

Authors:  Agnès Delaunay; Delphine Pflieger; Marie Bénédicte Barrault; Joelle Vinh; Michel B Toledano
Journal:  Cell       Date:  2002-11-15       Impact factor: 41.582

6.  TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum.

Authors:  Shane R Wilkinson; Martin C Taylor; Said Touitha; Isabel L Mauricio; David J Meyer; John M Kelly
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

7.  Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins.

Authors:  Zachary A Wood; Leslie B Poole; Roy R Hantgan; P Andrew Karplus
Journal:  Biochemistry       Date:  2002-04-30       Impact factor: 3.162

8.  Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum.

Authors:  Helena Castro; Carla Sousa; Marta Santos; Anabela Cordeiro-da-Silva; Leopold Flohé; Ana M Tomás
Journal:  Free Radic Biol Med       Date:  2002-12-01       Impact factor: 7.376

9.  Specificity and kinetics of a mitochondrial peroxiredoxin of Leishmania infantum.

Authors:  Helena Castro; Heike Budde; Leopold Flohé; Birgit Hofmann; Heinrich Lünsdorf; Joseph Wissing; Ana M Tomás
Journal:  Free Radic Biol Med       Date:  2002-12-01       Impact factor: 7.376

10.  Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum.

Authors:  Shane R Wilkinson; Samson O Obado; Isabel L Mauricio; John M Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-26       Impact factor: 11.205

View more
  12 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance.

Authors:  Tim Downing; Hideo Imamura; Saskia Decuypere; Taane G Clark; Graham H Coombs; James A Cotton; James D Hilley; Simonne de Doncker; Ilse Maes; Jeremy C Mottram; Mike A Quail; Suman Rijal; Mandy Sanders; Gabriele Schönian; Olivia Stark; Shyam Sundar; Manu Vanaerschot; Christiane Hertz-Fowler; Jean-Claude Dujardin; Matthew Berriman
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

3.  Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials.

Authors:  Susan Wyllie; Tim J Vickers; Alan H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  2008-02-04       Impact factor: 5.191

4.  The conformational bases for the two functionalities of 2-cysteine peroxiredoxins as peroxidase and chaperone.

Authors:  Janine König; Helena Galliardt; Patrick Jütte; Simon Schäper; Lea Dittmann; Karl-Josef Dietz
Journal:  J Exp Bot       Date:  2013-07-04       Impact factor: 6.992

5.  Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism.

Authors:  Janine König; Susan Wyllie; Geoffrey Wells; Malcolm F Stevens; Paul G Wyatt; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

6.  Mitochondrial redox metabolism in trypanosomatids is independent of tryparedoxin activity.

Authors:  Helena Castro; Susana Romao; Sandra Carvalho; Filipa Teixeira; Carla Sousa; Ana M Tomás
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

7.  Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity.

Authors:  Helena Castro; Filipa Teixeira; Susana Romao; Mariana Santos; Tânia Cruz; Manuela Flórido; Rui Appelberg; Pedro Oliveira; Frederico Ferreira-da-Silva; Ana M Tomás
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

8.  ATP-dependent ligases in trypanothione biosynthesis--kinetics of catalysis and inhibition by phosphinic acid pseudopeptides.

Authors:  Sandra L Oza; Shoujun Chen; Susan Wyllie; James K Coward; Alan H Fairlamb
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

9.  Structural and mechanistic insights into type II trypanosomatid tryparedoxin-dependent peroxidases.

Authors:  Magnus S Alphey; Janine König; Alan H Fairlamb
Journal:  Biochem J       Date:  2008-09-15       Impact factor: 3.857

10.  Proteome analysis and serological characterization of surface-exposed proteins of Rickettsia heilongjiangensis.

Authors:  Yong Qi; Xiaolu Xiong; Xile Wang; Changsong Duan; Yinjun Jia; Jun Jiao; Wenping Gong; Bohai Wen
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.